SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020.

Liza CoyerAnders BoydJanke SchinkelCharles AgyemangHenrike GalenkampAnitra D M KoopmanTjalling LeenstraEric P Moll van CharanteBert-Jan H van den BornAnja LokArnoud VerhoeffAeilko H ZwindermanSuzanne JurriaansLonneke A van VughtKarien StronksMaria Prins

Published in: BMJ open (2022)

No remarkable differences in SARS-CoV-2 seroprevalence were observed between the largest ethnic groups in Amsterdam after the first wave of infections. The higher infection seroprevalence observed among Ghanaians, which passed mostly unnoticed, warrants wider prevention efforts and opportunities for non-symptom-based testing.

Keyphrases

sars cov
respiratory syndrome coronavirus
risk factors
quality improvement
patient reported